Toggle light / dark theme

Are you — is every person you’ve ever loved, every incredible sight you’ve ever witnessed — part of a hologram? Some scientists think so.

They argue that all the information in the universe may be stored on some sort of two-dimensional object. In this video, NASA astronomer Michelle Thaller delves into frontier science — an unchartered territory that may require a new level of physics to better understand.

The future of medicine is not fixing what is broken, it’s preventing things from getting broken in the first place.


The leading cause of death in Texas is heart disease, according to the National Center for Health Statistics, accounting for more than 45,000 deaths statewide in 2017. A new wearable technology made from stretchy, lightweight material could make heart health monitoring easier and more accurate than existing electrocardiograph machines—a technology that has changed little in almost a century.

Developed by engineers at The University of Texas at Austin and led by Nanshu Lu in the Cockrell School of Engineering, this is the latest incarnation of Lu’s electronic tattoo technology, a graphene-based that can be placed on the skin to measure a variety of body responses, from electrical to biomechanical signals.

The research team reported on their newest e-tattoo in a recent issue of Advanced Science.

More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson’s disease. In a new study led by scientists from the School of Veterinary Medicine, researchers found that an enzyme in the body can metabolize compounds formed in the brain from alkaloids present in certain foods and tobacco into MPTP-like chemicals, triggering a neurodegenerative condition in mice.

The researchers, led by Narayan Avadhani and Mrittika Chattopadhyay, suggest that the enzyme, mitochondrial CYP2D6, presents a potentially powerful new target for Parkinson’s treatment.

“Over the past two or three decades, researchers have tried inhibiting the process by which they believed MPTP was metabolized, with mixed success,” says Avadhani. “We believe that mitochondrial CYP2D6 is the more direct drug target, which might prove better in treating idiopathic Parkinson’s disease.”

Scientists at Lancaster University have announced that they have invented an electronic memory device that realises the dream of universal memory – a previously hypothetical technology long considered to be revolutionary for the industry.

Universal memory is a computer data storage technology that until now has been purely conceptual, combining the speed and low cost of dynamic random-access memory (DRAM) and the stability of flash memory. This also would result in significantly lower power consumption.

It had been considered impossible by some in the field, but scientists at Lancaster University say that the electronic memory device they have invented and patented is the realisation of the universal memory dream.